Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Eric Pillado

Vascular Surgery Stanford, CA Medical Doctor

NPI 1871097337 CMS profile 5703164

300 Pasteur Dr, Ste 650, Stanford, CA 94305

Open in the dashboard

General payments

$18,625

86 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Pillado of Stanford, CA is reported in the CMS Open Payments database as having received $18,625 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,439 31
2024 General $3,025 24
2023 General $178 5
2022 General $6,940 24
2021 General $5,043 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Pillado
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Eric Pillado were reported at $3,439. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Eric Pillado Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $5,043 $471 $158–$1,421 $132
2022 $6,940 $725 $222–$2,183 $149
2023 $178 $836 $257–$2,440 $160
2024 $3,025 $909 $252–$2,619 $164
2025 $3,439 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $12,732 34 payments
  2. Abbott Laboratories $2,511 16 payments
  3. Silk Road Medical, Inc. $2,075 13 payments
  4. Boston Scientific Corporation $346 7 payments
  5. W. L. Gore & Associates, Inc. $313 3 payments
  6. Shockwave Medical, Inc $280 3 payments
  7. Bolton Medical Inc $140 5 payments
  8. Cook Medical LLC $100 1 payment
  9. LimFlow Inc. $44 1 payment
  10. Cardiovascular Systems Inc. $34 1 payment
  11. Other $50 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $10,000 2 payments
  2. Travel and Lodging $4,141 18 payments
  3. Food and Beverage $4,116 65 payments
  4. Education $368 1 payment
Products named General payments · program years 2021–2025
  1. ENDURANT IIS $7,201 28 payments
  2. Endurant $5,000 1 payment
  3. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $2,075 13 payments
  4. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $2,075 13 payments
  5. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $2,075 13 payments
  6. ENROUTE Transcarotid Stent $2,075 13 payments
  7. PROSTAR $2,027 11 payments
  8. ESPRIT $276 2 payments
  9. SUPERA $207 3 payments
  10. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $179 1 payment
  11. Other $1,374 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record